BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 24390282)

  • 1. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.
    Huang Q; Whitington T; Gao P; Lindberg JF; Yang Y; Sun J; Väisänen MR; Szulkin R; Annala M; Yan J; Egevad LA; Zhang K; Lin R; Jolma A; Nykter M; Manninen A; Wiklund F; Vaarala MH; Visakorpi T; Xu J; Taipale J; Wei GH
    Nat Genet; 2014 Feb; 46(2):126-35. PubMed ID: 24390282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOXB13, RFX6 and prostate cancer risk.
    Mills IG
    Nat Genet; 2014 Feb; 46(2):94-5. PubMed ID: 24473320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants.
    Spisák S; Lawrenson K; Fu Y; Csabai I; Cottman RT; Seo JH; Haiman C; Han Y; Lenci R; Li Q; Tisza V; Szállási Z; Herbert ZT; Chabot M; Pomerantz M; Solymosi N; ; Gayther SA; Joung JK; Freedman ML
    Nat Med; 2015 Nov; 21(11):1357-63. PubMed ID: 26398868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOXB13 and a SNP collaborate to increase risk.
    Payton S
    Nat Rev Urol; 2014 Feb; 11(2):64. PubMed ID: 24473413
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of THADA, FOXP4, GPRC6A/RFX6 genes and 8q24 risk alleles with prostate cancer in Northern Chinese men.
    Li XH; Xu Y; Yang K; Shi JJ; Zhang X; Yang F; Yuan H; Zhu X; Zhang YH; Wang JY; Yang Z
    J BUON; 2015; 20(5):1223-8. PubMed ID: 26537068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility loci associations with prostate cancer risk in northern Chinese men.
    Wang NN; Xu Y; Yang K; Wei D; Zhang YG; Liu M; Shi XH; Liang SY; Sun L; Zhu XQ; Yang YG; Tang L; Zhao CX; Wang X; Chen X; Hui J; Zhang YH; Zhu L; Yang F; Zhang YR; Yang Z; Wang JY
    Asian Pac J Cancer Prev; 2013; 14(5):3075-8. PubMed ID: 23803082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication and fine mapping for association of the C2orf43, FOXP4, GPRC6A and RFX6 genes with prostate cancer in the Chinese population.
    Long QZ; Du YF; Ding XY; Li X; Song WB; Yang Y; Zhang P; Zhou JP; Liu XG
    PLoS One; 2012; 7(5):e37866. PubMed ID: 22662242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA2 co-opts TGFβ1/SMAD4 oncogenic signaling and inherited variants at 6q22 to modulate prostate cancer progression.
    Yang X; Zhang Q; Li S; Devarajan R; Luo B; Tan Z; Wang Z; Giannareas N; Wenta T; Ma W; Li Y; Yang Y; Manninen A; Wu S; Wei GH
    J Exp Clin Cancer Res; 2023 Aug; 42(1):198. PubMed ID: 37550764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium.
    Wang M; Liu F; Hsing AW; Wang X; Shao Q; Qi J; Ye Y; Wang Z; Chen H; Gao X; Wang G; Chu LW; Ding Q; OuYang J; Gao X; Huang Y; Chen Y; Gao YT; Zhang ZF; Rao J; Shi R; Wu Q; Zhang Y; Jiang H; Zheng J; Hu Y; Guo L; Lin X; Tao S; Jin G; Sun J; Lu D; Zheng SL; Sun Y; Mo Z; Yin C; Zhang Z; Xu J
    Carcinogenesis; 2012 Feb; 33(2):356-60. PubMed ID: 22114074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
    Jin HJ; Jung S; DebRoy AR; Davuluri RV
    Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Interaction of
    Sipeky C; Gao P; Zhang Q; Wang L; Ettala O; Talala KM; Tammela TLJ; Auvinen A; Wiklund F; Wei GH; Schleutker J
    Clin Cancer Res; 2018 Dec; 24(24):6265-6276. PubMed ID: 30181389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.
    Shin S; Oh S; An S; Janknecht R
    Oncol Rep; 2013 Jan; 29(1):306-14. PubMed ID: 23076342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
    Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
    Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The homeodomain protein HOXB13 regulates the cellular response to androgens.
    Norris JD; Chang CY; Wittmann BM; Kunder RS; Cui H; Fan D; Joseph JD; McDonnell DP
    Mol Cell; 2009 Nov; 36(3):405-16. PubMed ID: 19917249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin interactions and candidate genes at ten prostate cancer risk loci.
    Du M; Tillmans L; Gao J; Gao P; Yuan T; Dittmar RL; Song W; Yang Y; Sahr N; Wang T; Wei GH; Thibodeau SN; Wang L
    Sci Rep; 2016 Mar; 6():23202. PubMed ID: 26979803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Modeling of complete HOXB13 protein for predicting the functional effect of SNPs and the associated role in hereditary prostate cancer.
    Chandrasekaran G; Hwang EC; Kang TW; Kwon DD; Park K; Lee JJ; Lakshmanan VK
    Sci Rep; 2017 Mar; 7():43830. PubMed ID: 28272408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility.
    Nguyen HH; Takata R; Akamatsu S; Shigemizu D; Tsunoda T; Furihata M; Takahashi A; Kubo M; Kamatani N; Ogawa O; Fujioka T; Nakamura Y; Nakagawa H
    Hum Mol Genet; 2012 May; 21(9):2076-85. PubMed ID: 22323358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
    Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
    PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic insights into genetic susceptibility to prostate cancer.
    Tian P; Zhong M; Wei GH
    Cancer Lett; 2021 Dec; 522():155-163. PubMed ID: 34560228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus.
    Zhang X; Cowper-Sal lari R; Bailey SD; Moore JH; Lupien M
    Genome Res; 2012 Aug; 22(8):1437-46. PubMed ID: 22665440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.